Table 1 Main demographic and clinical features of the study group
Variables | p-value (n = 68) | Â |
|---|---|---|
Age, years (median IQR) | 39 (25–59) |  |
Gender | Â | Â |
Male, n. pts (%) | 31 (45) | 0. 6 |
Female, n. pts (%) | 37 (55) | |
Anti AchR Ab, nmol/L (median IQR) | 3.1 (2.0-4.0) | Â |
Score MG (median IQR) | 23 (14–29) |  |
Symptom duration | Â | Â |
&<12 months, n. pts (%) | 20 (29) | 0.69 |
&12 months, n. pts (%) | 48 (71) | |
Oropharyngeal symptoms | Â | Â |
&Yes, n. pts (%) | 36 (53) | 0.91 |
&No, n. pts (%) | 32 (47) | |
MGFA classification | Â | Â |
&Class I, n. pts (%) | 6 (9) | 0.06 |
&Class II, n. pts (%) | 40 (59) | |
&Class III, n. pts (%) | 22 (32) | |
Histology | Â | Â |
&Hyperplasia, n. pts (%) | 27 (40) | 0.89 |
&Atrophia, n. pts (%) | 23 (34) | |
&Normal, n. pts (%) | 18 (26) | |
Thymic germinal centers, n. pts (%) | 33 (48) | Â |
&Ectopic tissue, n. pts (%) | 37 (54) | Â |
&Ectopic germinal centers, n. pts (%) | 23 (34) | Â |